Sort By

  • Newest

  • Newest

  • Oldest

  • Author Name

  • Author Name

  • David Chaplin

  • Drew Meredith

  • Giselle Roux

  • Greg Bright

  • James Dunn

  • Lachlan Maddock

ASX update; COVID-19 impacting Macquarie Group

Vaccine trial restart boosts markets, ASX strength to continue, COVID-19 impacting Macquarie Group A positive lead from Wall Street and news that AstraZeneca plc (NYSE:AZN) had resumed their vaccine trial sent the ASX 200 (ASX:XJO) 0.7% higher on Monday. Positive news on the vaccine front support the energy and industrial sectors amid hope of a…
Drew Meredith | 14th Sep 2020 | More
ASX shares update; QBEs culture crisis, RBA looking dovish

August gains lost in a day, QBEs culture crisis, RBA looking dovish, higher open ahead With reporting season complete, markets are once again turning to economic data and vaccine hopes. It wasn’t a great start to Spring, with the ASX 200 (ASX:XJO) falling 1.8% and giving back nearly all the gains achieved in August. The…
Drew Meredith | 1st Sep 2020 | More
“What happens when we go back to the office?” COVID-19 risks for financial advisers.

The focus of health and safety regulators has been on helping employers implement measures to minimise the risk of employees either contracting COVID-19 at work or bringing it to work.
Ishan Dan | 25th Aug 2020 | More
    • Not even normal for a crash

    Stock markets have crashed, we can be confident of that. History suggests there is no quick recovery from crashes like these, which means lasting consequences for investors.
    Contributor | 18th Mar 2020 | More
    A 10-point plan to avoid recession

    The world economy is teetering on a knife edge: the Chinese and Indian economies were slowing even before the COVID-19 Coronavirus, and as Australia was recovering from one of its worst bushfires.
    Contributor | 10th Mar 2020 | More